Advisor Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Advisor Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$14K	Hold	14,176	–	–	﹤0.01%	4159
2019 Q3	$15K	Hold	14,176	–	–	﹤0.01%	4141
2019 Q2	$26K	Hold	14,176	–	–	﹤0.01%	3818
2019 Q1	$27K	Hold	14,176	–	–	﹤0.01%	3813
2018 Q4	$17K	Hold	14,176	–	–	﹤0.01%	3939
2018 Q3	$38K	Hold	14,176	–	–	﹤0.01%	3487
2018 Q2	$27K	Hold	14,176	–	–	﹤0.01%	3533
2018 Q1	$30K	Hold	14,176	–	–	﹤0.01%	3435
2017 Q4	$29K	Sell	14,176 -59,740	-81%	-$124K	﹤0.01%	3471
2017 Q3	$98K	Buy	73,916 +25,250	+52%	+$31.4K	﹤0.01%	2427
2017 Q2	$76K	Buy	48,666 +14,176	+41%	+$27.3K	﹤0.01%	2530
2017 Q1	$111K	Hold	34,490	–	–	﹤0.01%	2083
2016 Q4	$47K	Buy	+34,490	New	+$45K	﹤0.01%	2660

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Advisor Group's INFI Position: Q4 2019 in Review

Advisor Group held its Infinity Pharmaceuticals, Inc. (INFI) position steady in Q4 2019 at 14,176 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Advisor Group first reported a position in INFI in Q4 2016 and has held it in 13 quarters since. The position peaked at $111K in Q1 2017. 47 funds tracked by Wall St. Rank hold INFI as of Q4 2019.

Advisor Group held 14,176 shares of Infinity Pharmaceuticals, Inc. worth $14K as of Q4 2019.
Advisor Group left its Infinity Pharmaceuticals, Inc. share count unchanged in Q4 2019.
Infinity Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4159 holding.
Advisor Group first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2016 and has held it in 13 quarters since.
Advisor Group's Infinity Pharmaceuticals, Inc. position peaked at $111K in Q1 2017.
47 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.